- Home
- IMKTA vs INVA Comparison
IMKTA vs INVA Comparison
Compare IMKTA & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMKTA | INVA |
|---|---|---|
| Founded | 1963 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 1994 | 2000 |
Fundamental Metrics
Financial Performance| Metric | IMKTA | INVA |
|---|---|---|
| Price | $91.79 | $23.04 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.80 |
| AVG Volume (30 Days) | 103.8K | ★ 541.3K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.71% | N/A |
| EPS Growth | N/A | ★ 816.67 |
| EPS | N/A | ★ 3.30 |
| Revenue | ★ $5,334,032,609.00 | $217,217,000.00 |
| Revenue This Year | N/A | $8.95 |
| Revenue Next Year | N/A | $12.65 |
| P/E Ratio | $15.91 | ★ $6.98 |
| Revenue Growth | N/A | ★ 62.63 |
| 52 Week Low | $59.09 | $16.52 |
| 52 Week High | $92.79 | $25.15 |
Technical Indicators
Market Signals| Indicator | IMKTA | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 67.27 | 58.21 |
| Support Level | $68.14 | $20.56 |
| Resistance Level | N/A | $25.15 |
| Average True Range (ATR) | 2.28 | 0.51 |
| MACD | 0.46 | 0.07 |
| Stochastic Oscillator | 88.35 | 69.23 |
Price Performance
Historical ComparisonAbout IMKTA Ingles Markets Incorporated
Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.